Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4690937

CC(=O)c1cccc(-c2cc3nc(N)nc(N)c3c3ccn(C)c23)c1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 5/20 0.52
HRH4 Q9H3N8 2/20 0.42
SLC2A1 P11166 1/20 0.37
PAX8 Q06710 1/20 0.36
ATR Q13535 2/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
GPR68 Q15743 1/20 0.35
ASH1L Q9NR48 1/20 0.34
PDE4D Q08499 1/20 0.34
PIK3CD O00329 1/20 0.33
ABL1 P00519 1/20 0.33
EGFR P00533 1/20 0.33
HCK P08631 1/20 0.33
SRC P12931 1/20 0.33
KDR P35968 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688806 0.93 DHFR (0.59) DHFRHRH4SLC2A1PAX8ATR
Trifluoroacetic Acid SCHEMBL4693910 0.90 DHFR (0.41) DHFRSLC2A1PAX8
Trifluoroacetic Acid SCHEMBL4692238 0.90 DHFR (0.41) DHFRHRH4SLC2A1PAX8SRC
Trifluoroacetic Acid SCHEMBL4687967 0.89 SLC2A1 (0.41) DHFRSLC2A1PAX8KDR
Trifluoroacetic Acid SCHEMBL4689915 0.89 SLC2A1 (0.41) DHFRSLC2A1PAX8ATR
Trifluoroacetic Acid SCHEMBL4692155 0.89 DHFR (0.40) DHFRSLC2A1PAX8PIK3CDABL1
Trifluoroacetic Acid SCHEMBL4693890 0.89 PI4K2A (0.42) DHFR
Trifluoroacetic Acid SCHEMBL4692005 0.88 MAP4K4 (0.41) DHFRSLC2A1
Trifluoroacetic Acid SCHEMBL4692244 0.88 DHFR (0.42) DHFRHRH4SLC2A1PAX8
Trifluoroacetic Acid SCHEMBL4693879 0.86 DHFR (0.38) DHFRSLC2A1PAX8KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262297-B2 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors HOFFMANN-LA ROCHE INC. (US) 2007-08-28 US claimed
US-20040235872-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors BERTHEL STEVEN JOSEPH (US) 2004-11-25 US claimed
EP-1628979-B1 DIAMINOPYRROLOQUINAZOLINES COMPOUNDS AS PROTEIN TYROSINE PHOSPHATASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20070270445-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors BERTHEL STEVEN J 2007-11-22 US disclosed
US-7262297-B2 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors HOFFMANN-LA ROCHE INC. (US) 2007-08-28 US disclosed
US-20040235872-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors BERTHEL STEVEN JOSEPH (US) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235872-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors PTPN5, PPP5C, PTP4A2 DHFR 289/4885HRH4 3216/4885SLC2A1 271/4885
US-20070270445-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors PTPN5, DUSP15, PPP5C DHFR 339/4885HRH4 4110/4885SLC2A1 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.